NextcureNXTC
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 26 institutions reported holding Nextcure Inc. (NXTC) in their 13F filings, up 2 from Q4 2025. 5 opened new positions and 4 sold out. The largest holders were Squadron Capital Management LLC ($2.8M), Affinity Asset Advisors, LLC ($2.6M) and Ikarian Capital, LLC ($2.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Nextcure Inc.
- CUSIP
- 65343E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2.4M |
| Exits | 4 | $503K |
All 13F filers, Q4 2025 → Q1 2026: 289,796 shares bought and 102,481 shares sold, net +187,315 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Squadron Capital Management LLC | 1.13% | Add +11.8% | 265,000 | $2.8M |
| Affinity Asset Advisors, LLC | 0.15% | Reduce -2.2% | 241,826 | $2.6M |
| Ikarian Capital, LLC | 0.36% | No change | 238,303 | $2.5M |
| Sofinnova Investments, Inc. | 0.12% | No change | 222,654 | $2.4M |
| Silverarc Capital Management, LLC | 0.22% | No change | 176,057 | $1.9M |
| Vanguard Capital Management LLC | 0.00% | — | 160,473 | $1.7M |
| Pfizer Inc | 0.64% | Reduce -2.7% | 153,354 | $1.5M |
| Opaleye Management Inc. | 0.20% | New | 141,181 | $1.5M |
| AWM Investment Company, Inc. | 0.14% | No change | 117,371 | $1.2M |
| Exome Asset Management LLC | 0.71% | Reduce -30.0% | 115,500 | $1.2M |
| Boothbay Fund Management, LLC | 0.02% | No change | 69,617 | $744K |
| Renaissance Technologies | 0.00% | Add +80.0% | 60,534 | $647K |
| Verdad Advisers, LP | 0.52% | New | 42,955 | $459K |
| Geode Capital Management, LLC | 0.00% | Add +34.3% | 31,092 | $327K |
| BlackRock, Inc. | 0.00% | No change | 27,793 | $297K |
| Woodline Partners LP | 0.00% | New | 27,498 | $294K |
| Cardiff Park Advisors, LLC | 0.02% | No change | 21,833 | $233K |
| Acadian Asset Management LLC | 0.00% | Reduce -29.1% | 18,982 | $199K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 16,015 | $168K |
| Citadel Advisors | 0.00% | New | 15,292 | $161K |
| Barclays PLC | 0.00% | No change | 5,626 | $60K |
| UBS Group AG | 0.00% | No change | 338 | $4K |
| Morgan Stanley | 0.00% | No change | 66 | $705 |
| JPMorgan Chase & Co. | 0.00% | No change | 61 | $587 |
| BNP Paribas Financial Markets | 0.00% | No change | 32 | $342 |
| Citigroup Inc. | 0.00% | New | 1 | $11 |
"% of holder's portfolio" is NXTC's weight in each manager's 13F, not the share of Nextcure Inc. the manager owns.